off-label use of medication;
experimentation or therapy;
informed consent;
civil liability of the physician;
D O I:
10.1163/15718093-12341352
中图分类号:
D9 [法律];
DF [法律];
学科分类号:
0301 ;
摘要:
Off-label use of medication refers to prescribing a registered medicine outside its approved marketing authorization, purpose, target group, or indication. Off-label prescription is a widely accepted practice. However, no or little regulation can be found. In this article, the legal status of off-label prescription will be examined. Does off-label prescription fall under the therapeutical freedom and is it free from regulation? Or should we equalize off-label prescription with a therapeutical experimentation and should it follow the rules of experimentation? I will also examine whether the patient can give an informed consent. Whether or not this is possible leads to intense discussions. Finally, the potential liability of the prescribing physician is of great importance.
机构:
US Dept HHS, Off Assistant Secretary Planning & Evaluat, Washington, DC 20201 USAUS Dept HHS, Off Assistant Secretary Planning & Evaluat, Washington, DC 20201 USA
机构:
Univ Lisbon, Fac Med, Ctr Estudos Med Baseada Evidencia, P-1699 Lisbon, PortugalUniv Lisbon, Fac Med, Ctr Estudos Med Baseada Evidencia, P-1699 Lisbon, Portugal
Carneiro, Antonio Vaz
Costa, Joao
论文数: 0引用数: 0
h-index: 0
机构:
Univ Lisbon, Fac Med, Ctr Estudos Med Baseada Evidencia, P-1699 Lisbon, PortugalUniv Lisbon, Fac Med, Ctr Estudos Med Baseada Evidencia, P-1699 Lisbon, Portugal
机构:
All Childrens Hosp, NICU, St Petersburg, FL USA
Univ S Florida, Tampa, FL USA
ANN, Tampa, FL USA
Sigma Theta Tau, Indianapolis, IN USA
Delta Beta chapter Iarge, Indianapolis, IN USAAll Childrens Hosp, NICU, St Petersburg, FL USA
机构:
Univ Tehran Med Sci, Endocrinol & Metab Clin Sci Inst, Endocrinol & Metab Res Ctr, Tehran, IranUniv Tehran Med Sci, Med Eth & Hist Med Res Ctr, Tehran, Iran